Indeed, the abilities of S2-FE to inhibit MMP-7 activity and the tumorigenic activities of colon cancer cells suggest that these peptides could potentially serve as effective anticancer drugs for colon cancer. The gene discussed is MMP7; the disease is malignant colon neoplasm.